Stocks Comparison
Dexcom vs Medline: revenue, profit, margins and growth compared
Dexcom brought in $4.7B of revenue in fiscal 2025, Medline $28.4B in fiscal 2025. Dexcom kept 17.9% of its revenue as net profit, Medline 4.1%. Free cash flow was $1.1B at Dexcom and $1.3B at Medline.
Side by side, latest fiscal year
| DXCM | MDLN | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $4.7B | $28.4B |
| Revenue growth | +15.6% | n/a |
| Net income | $836.3M | $1.2B |
| Net margin | 17.9% | 4.1% |
| Free cash flow | $1.1B | $1.3B |
| Free cash flow margin | 23.1% | 4.6% |
| Earnings per share (diluted) | $2.09 | -$0.01 |
| Cash | $917.7M | $1.9B |
| Debt | n/a | $12.6B |
| Price to earnings | 41.4 | n/a |
| Market value | $32.7B | $45.6B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #65 of 523 · Health care | #23 of 523 · Health care |
Over the years
DXCM $4.7BMDLN $28.4B
DXCM $836.3MMDLN $1.2B
DXCM 17.9%MDLN 4.1%
DXCM +15.6%MDLN +9.8%
DXCM $1.1BMDLN $1.3B
Questions about Dexcom and Medline
Which is bigger by revenue, Dexcom or Medline?
Medline is bigger by revenue: $28.4B in fiscal 2025, against $4.7B for Dexcom in fiscal 2025.
Which keeps more of its revenue as profit, Dexcom or Medline?
Dexcom had a net margin of 17.9% in fiscal 2025; Medline had 4.1% in fiscal 2025.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.